OCUGEN INC. - COMMON STOCK

Ocugen CSO to Participate in 3rd Annual Gene Therapy for Ophthalmic Disorders Conference

08 9月 2022 06:30:00 条件 Nasdaq GlobeNewswire

Ocugen, Inc. to Present at H.C. Wainwright 24th Annual Global Investment Conference

06 9月 2022 06:30:00 条件 Nasdaq GlobeNewswire

Ocugen Appoints Robert J. Hopkins, MD, MPH & TM, FACP, FIDSA, as Chief Medical Officer and Promotes Arun Upadhyay, PhD, to Chief Scientific Officer

01 9月 2022 06:30:16 条件 Nasdaq GlobeNewswire

Ocugen CEO to Present at H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference

12 8月 2022 06:30:22 条件 Nasdaq GlobeNewswire

Ocugen Provides Business Update & Second Quarter 2022 Financial Results

05 8月 2022 06:30:26 条件 Nasdaq GlobeNewswire

Ocugen To Host Conference Call on Friday, August 5 at 8:30 a.m. ET to Discuss Business Updates and Second Quarter 2022 Financial Results

29 7月 2022 06:30:58 条件 Nasdaq GlobeNewswire

Ocugen Announces Publication of Positive Results of COVID-19 Vaccine Trial for Children 2-18 in The Lancet Infectious Diseases

21 6月 2022 06:00:00 条件 Nasdaq GlobeNewswire

Ocugen Named Among Philadelphia’s ‘2022 Best Places to Work’

14 6月 2022 06:00:00 条件 Nasdaq GlobeNewswire

Ocugen, Inc. Announces Issuance of U.S. Patent for Treating Retinal Degenerative Diseases Using Gene Therapy

13 6月 2022 06:00:00 条件 Nasdaq GlobeNewswire

Ocugen, Inc. to Present at BIO International Convention 2022

09 6月 2022 17:17:10 条件 Nasdaq GlobeNewswire

Ocugen Announces New Cell Therapy Program Following FDA Regenerative Medicine Advanced Therapy (RMAT) Recognition

24 5月 2022 06:11:00 条件 Nasdaq GlobeNewswire

Ocugen, Inc. to Present at H.C. Wainwright Global Investment Conference

23 5月 2022 06:34:00 条件 Nasdaq GlobeNewswire

Ocugen Announces FDA Removes Clinical Hold on Phase 2/3 Clinical Trial for COVAXIN™ (BBV152)

23 5月 2022 05:36:00 条件 Nasdaq GlobeNewswire

Ocugen Provides Business Update and First Quarter 2022 Financial Results

06 5月 2022 05:33:00 条件 Nasdaq GlobeNewswire

Ocugen to Host Conference Call on Friday, May 6 at 8:30 a.m. ET to Provide Business Update and Discuss First Quarter 2022 Financial Results

02 5月 2022 06:37:00 条件 Nasdaq GlobeNewswire

Ocugen, Inc. to Present Preclinical Results at The Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Meeting

29 4月 2022 10:36:00 条件 Nasdaq GlobeNewswire

Ocugen, Inc. Announces Positive DSMB Recommendation for OCU400-101 Clinical Trial

25 4月 2022 06:33:00 条件 Nasdaq GlobeNewswire

Ocugen, Inc. to Present at NobleCon18

19 4月 2022 16:32:00 条件 Nasdaq GlobeNewswire

Ocugen, Inc. to Commercialize COVAXIN™ in Mexico, Rights Now Encompassing All of North America

18 4月 2022 06:11:00 条件 Nasdaq GlobeNewswire

Ocugen, Inc. Provides Update on its Phase 2/3 Study of COVAXIN™ (BBV152)

12 4月 2022 07:31:00 条件 Nasdaq GlobeNewswire